Leonardo de la Parra Soto

Leo graduated from Tecnológico de Monterrey, Mexico in December 2024 with a B.S. in Biotechnology Engineering. During his junior year, he conducted research on nanobiomaterial-based cancer immunotherapy at Brigham and Women's Hospital, Harvard Medical School, and the Wyss Institute as part of the Artzi Lab. He joined the Müschen Lab in October 2025, where he's investigating ferroptosis and the modulation of oncogenic tyrosine kinase signaling as novel strategies to induce cell death in B cell malignancies as part of his preparation for graduate school.